Back to VRTX Stock Lookup

Vertex Pharma (VRTX) – Company Press Releases

Nov 20, 2014 04:01 PM Vertex to Present at Deutsche Bank BioFEST on December 2
Nov 5, 2014 07:00 AM Vertex Submits Applications in the U.S. and Europe for Approval of Lumacaftor in Combination with Ivacaftor for People with Cystic Fibrosis Who Have Two Copies of the F508del Mutation
Oct 30, 2014 04:01 PM Vertex to Present at the Credit Suisse Healthcare Conference on November 11
Oct 28, 2014 04:01 PM Vertex Reports Third Quarter 2014 Financial Results
Oct 21, 2014 04:47 PM FDA Advisory Committee Recommends Approval of KALYDECO® (ivacaftor) for Use in People with Cystic Fibrosis Ages 6 and Older Who Have the R117H Mutation
Oct 14, 2014 04:01 PM Vertex to Announce Third Quarter 2014 Financial Results on October 28
Oct 9, 2014 09:32 AM Vertex Reviews Recent Progress and Announces Upcoming Milestones in the Development of Multiple Combinations of Medicines that Target the Underlying Cause of Cystic Fibrosis
Sep 8, 2014 09:00 AM Vertex Announces Upcoming Presentations of Data at North American Cystic Fibrosis Conference - October 9 to 11, 2014
Sep 2, 2014 04:01 PM Vertex to Present at the Morgan Stanley Global Healthcare Conference on September 10

Back to VRTX Stock Lookup